Form S-1/A BOA Acquisition Corp. II For: 5 May

J&J’s JNJ-4804 shows improved outcomes in bowel disease trial

Investing.com · News 9m ago

J&J’s Tremfya shows efficacy in fistulizing Crohn’s disease

Investing.com · News 9m ago

OpenWorld to tokenize equity on Figure’s blockchain platform

Investing.com · News 9m ago

AbbVie presents IBD data at digestive disease conference

Investing.com · News 9m ago

Palantir falls premarket; ServiceNow, PayPal rise

Investing.com · Investing_news 11m ago

Stock Market Today: Dow Rises Amid U.S.-Iran Tensions; Palantir Slides After Earnings Report (Live Coverage)

Investor's Business Daily · Finance 14m ago

Behind the Trump Administration’s Potential Rethink on A.I.

The New York Times · Business 15m ago

3 AI Stocks Under $50 That Could Be This Year's Biggest Surprises

Motley Fool · Finance 17m ago

Argentina's auto parts industry feels the pain from Milei's shock therapy

Reuters · Finance 17m ago

Prospect Capital insiders are buying while yield hunters debate the safety

24/7 Wall St. · Finance 17m ago